“…BMP7, SMAD2, TGF-B1, and WNT6 (57) as well as FGF19 (58) have been proposed for FOXC1. Although the relevant FOXC1 targets during craniofacial development are not fully defined, Msx2 is an interesting candidate (59,60). In this regard, enhanced FOXC1 activity due to loss of SUMO modification could result in abnormal up-regulation of Msx2 and could promote the development of abnormalities such as Boston type craniosynostosis.…”